Skip to main content
. 2020 May 27;21(11):3805. doi: 10.3390/ijms21113805

Table 2.

SUCRA values by different treatments in BRCAwt patients.

Treatment Efficacy
Treatment SUCRA Rank
PARPi 90% 1
BEV 60% 2
CT 0% 3

SUCRA: surface under the cumulative ranking value; PARPi: poly (ADP-ribose) polymerase inhibitors; BEV bevacizumab; CT: chemotherapy without maintenance treatment.